MIST (Milestone Pharmaceuticals) FCF Margin %: -6,763.87% (As of Mar. 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.25
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals FCF Margin %?

Milestone Pharmaceuticals MIST -1.33% 26 FCF Margin % is -6,763.87% as of Mar. 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, Milestone Pharmaceuticals ranks worse than 85.92% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Milestone Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-16.10 Mil. Milestone Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.24 Mil. Therefore, Milestone Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -6,763.87%.

As of today, Milestone Pharmaceuticals's current FCF Yield % is -33.08%.

The historical rank and industry rank for Milestone Pharmaceuticals's FCF Margin % or its related term are showing as below:

MIST' s FCF Margin % Range Over the Past 10 Years
Min: -4653.6   Med: -2123.24   Max: -221.49
Current: -2885.82

During the past 9 years, the highest FCF Margin % of Milestone Pharmaceuticals was -221.49%. The lowest was -4653.60%. And the median was -2123.24%.

MIST's FCF Margin % is ranked worse than
85.92% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs MIST: -2885.82

Milestone Pharmaceuticals FCF Margin % Related Terms

Milestone Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals FCF Margin % Chart

Milestone Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -221.49 -1,054.82 -4,653.60 0.00 -3,191.66

Milestone Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -844.63 -6,763.87

MIST vs TLSA, DTIL, OKUR: FCF Margin % Comparison

For the Biotechnology subindustry, Milestone Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Milestone Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Milestone Pharmaceuticals's FCF Margin % falls into.


MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Milestone Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-49.343/1.546
=-3,191.66 %

Milestone Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-16.098/0.238
=-6,763.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -6,763.87% mean?
Milestone Pharmaceuticals (MIST) has a FCF Margin % of -6,763.87% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Milestone Pharmaceuticals and its competitors. According to the industry distribution chart, Milestone Pharmaceuticals ranks #824 out of 959 companies in the Biotechnology industry, placing it in the top 85.9%.
Is Milestone Pharmaceuticals' FCF Margin % too high?
Milestone Pharmaceuticals' current FCF Margin % is -6,763.87%. Based on the distribution chart, Milestone Pharmaceuticals ranks #824 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' FCF Margin % compare to TLSA and DTIL?
According to the Biotechnology industry distribution chart, Milestone Pharmaceuticals ranks #824 out of 959 companies for FCF Margin %. This places Milestone Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current FCF Margin % is -6,763.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current FCF Margin % of -6,763.87%. The current FCF Margin % is -6,763.87%. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current FCF Margin % is -6,763.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price